The study protocol received approval from the Institutional Review Board at the University of Florida, USA (Approval code: IRB201900262)
Casanas-Sanchez V, Perez JA, Fabelo N, Herrera-Herrera AV, Fernandez C, Marin R et al
Within this framework, Sermorelin and Ipamorelin are believed to occupy distinct but converging conceptual roles
The second class is inhibitors of the GLP-1 degrading enzyme, dipeptidyl pepitidase IV (Sitagliptin and related drugs) which can be given orally and increase the plasma level of GLP-1 and other peptides degraded by DPP-4
Furthermore, when harmful bacteria begin thriving in these lesions, it triggers swelling aggravating the breakout